Severe Recurrent Epistaxis - The Main Symptom of Hereditary Haemorrhagic Teleangiectasia

1. Garcia RID, Cecatto SB, Costa KS, Veiga FA, Uvo IP, Rapoport PB. Síndrome de Rendu-Osler-Weber: tratamento clínico e cirúrgico. Revista Brasileira de Otorrinolaringologia 2003; 69 (4): 577-580.10.1590/S0034-72992003000400022Search in Google Scholar

2. Grand’Maison A. Hereditary haemorrhagic telangiectasia. CMAJ : Canadian Medical Association Journal 2009; 180 (8): 833–835.10.1503/cmaj.081739Search in Google Scholar

3. Sadick H, Sadick M, Götte K, et al. Hereditary haemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measure. Wien Klin Wochenschr 2006;118(3-4): 72.10.1007/s00508-006-0561-xSearch in Google Scholar

4. Sharathkumar A, Shapiro A. Hereditary haemorrhagic telangiectasia. Haemophilia 2008; 14(6): 1269–1280.10.1111/j.1365-2516.2008.01774.xSearch in Google Scholar

5. Sautter NB, Smith TL. Treatment of hereditary haemorrhagic telangiectasia-related epistaxis. Otolaryngol Clin North Am 2016; 49(3):639-654.10.1016/j.otc.2016.02.010Search in Google Scholar

6. van Gent MWF, Velthuis S, Post MC, Snijder RJ, Westermann CJJ, Letteboer TGW, Mager JJ. Hereditary haemorrhagic telangiectasia: How accurate are the clinical criteria? Am J Med Genet Part A 2013; 161A: 461–466.10.1002/ajmg.a.35715Search in Google Scholar

7. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary haemorrhagic telangiectasia (Rendu Osler Weber syndrome). Am J Med Genet 2000; 91(1): 66–67.10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-PSearch in Google Scholar

8. Invernizzi, R, Quaglia, F, Klersy, C, Pagella, F, Ornati, F, Chu, F, Balduini, CL. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a prospective phase II clinical trial. The Lancet. Haematology 2015; 2(11), 465–473.10.1016/S2352-3026(15)00195-7Search in Google Scholar

9. Kim JY, Oh JH, Kim GT, Kwon JH. Endoscopic cryotherapy for the treatment of epistaxis due to hereditary haemorrhagic telangiectasia. J Craniofac Surg. 2014; 25(2):120-2.10.1097/SCS.0000000000000453Search in Google Scholar

10. Thomson RS, Molin NL, Whitehead KJ, Ashby S, Johnson L, Ward PD, McRae BR, Wilson KF, McDonald J. The effects of nasal closure on quality of life in patients with hereditary haemorrhagic telangiectasia. Laryngoscope investigative otolaryngology 2018; 3: 178–181.10.1002/lio2.157Search in Google Scholar

11. Papaspyrou G et al. Combined therapy for epistaxis by hereditary haemorrhagic telangiectasia: A 3-year follow up study on 45 patients. Journal of Cranio-Maxillo-Facial Surgery 2017; 45(8):1179–82.10.1016/j.jcms.2017.05.01828615135Search in Google Scholar

12. Richmon JD, Tian Y, Husseman J, Davidson TM. Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary haemorrhagic telangiectasia epistaxis. Am J Rhinol. 2007; 21:187-91.10.2500/ajr.2007.21.296917424877Search in Google Scholar

13. Robinson AE, McAuliffe W, Phillips TJ, Phatouros CC, Singh TP. Embolization for the treatment of intractable epistaxis: 12 month outcomes in a two centre case series. Br J Radiol. 2017; 90(1080):20170472.10.1259/bjr.20170472604763828972795Search in Google Scholar

14. Elden L, Montanera W, Terbrugge K. et al. Angiographic embolization for the treatment of epistaxis: a review of 108 cases. Otolaryngol Head Neck Surg 1994;111: 44–50.10.1177/0194599894111001108028941Search in Google Scholar

15. Pohar C, Mazeron JJ, Ghilezan M et al. Management of epistaxis in Rendu-Osler disease: is brachytherapy effective? International Journal of Radiation Oncology Biology Physics 1993; 27(5): 1073-77.Search in Google Scholar

16. McDermott AM, O’Cathain E, Carey BW, O’Sullivan P, Sheahan P. Sphenopalatine Artery Ligation for Epistaxis: Factors Influencing Outcome and Impact of Timing of Surgery. Otolaryngol Head Neck Surg. 2016; 154(3): 547-52.10.1177/019459981562013426602929Search in Google Scholar

17. Willems PWA, Farb RI, Agid R. Endovascular treatment of epistaxis. American Journal of Neuroradiology 2009; 30(9):1637-1645. h10.3174/ajnr.A1607705151519372207Search in Google Scholar

18. Duncan IC, Van Der Nest L. Intralesional Bleomycin Injections for the Palliation of Epistaxis in Hereditary Haemorrhagic Telangiectasia. AJNR 2004; 25(7): 1144-1146.Search in Google Scholar

19. Richer SL, Geisthoff UW, Livada N, Ward PD, Johnson L, Mainka A, Henderson KJ, Maune S, White RI Jr, Ross DA. The Young’s procedure for severe epistaxis from hereditary haemorrhagic telangiectasia. 2012; 26(5):401-4.10.2500/ajra.2012.26.3809Search in Google Scholar

20. Bequignon E, Vérillaud B, Robard L, Michel J, Prulière Escabasse V, Crampette L, Malard O. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017; 134(3):185-189.10.1016/j.anorl.2016.09.00827789155Search in Google Scholar

21. Elden L, Montanera W, Terbrugge K. et al. Angiographic embolization for the treatment of epistaxis: a review of 108 cases. Otolaryngol Head Neck Surg 1994;111: 44–50.10.1177/019459989411100110Search in Google Scholar

22. Pohar C, Mazeron JJ, Ghilezan M et al. Management of epistaxis in Rendu-Osler disease: is brachytherapy effective? International Journal of Radiation Oncology Biology Physics 1993; 27(5): 1073-77.10.1016/0360-3016(93)90526-2Search in Google Scholar

23. Donato M Pimentel J, Cabral R, Escada P. Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Haemorrhagic Telangiectasia. Acta Médica Portuguesa 2018; 31(1): 63.10.20344/amp.880229573771Search in Google Scholar

24. Fiorella ML, Ross D, Henderson KJ, White RI. Outcome of septal dermoplasty in patients with hereditary haemorrhagic telangiectasia. Laryngoscope 2005;115(2):301–5.10.1097/01.mlg.0000154754.39797.4315689755Search in Google Scholar

25. Whitehead KJ, Sautter NB, McWilliams JP, et al. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Haemorrhagic Telangiectasia A Randomized Clinical Trial 2016; 316(9): 943–951.10.1001/jama.2016.11724Search in Google Scholar

26. Lund VJ, Darby Y, Rimmer J, Amin M, Husain S. Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young’s procedure: a 22-year experience. Rhinology 2017; 55(2): 135-141.10.4193/Rhin16.31528064338Search in Google Scholar

27. Wirsching KEC, Kuhnel TS. Update on clinical strategies in hereditary haemorrhagic telangiectasia from an ENT point of view. Clin Exp Otorhinolaryngology 2017; 10(4): 153–157.10.21053/ceo.2016.00318Search in Google Scholar